Oncolytics Biotech

-$0.01 (-0.38%) Today
+$0.01 (+0.38%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell ONCY and other stocks, options, and ETFs commission-free!

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

CEO
Matthew C. Coffey
Employees
25
Headquarters
Calgary, Alberta
Founded
1998

ONCY Key Statistics

Market Cap
142.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
660.21K
High Today
$2.72
Low Today
$2.64
Open Price
$2.68
Volume
434.59K
52 Week High
$4.83
52 Week Low
$1.52

ONCY Earnings

-$0.71
-$0.47
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
-$0.10 per share
Replay Earnings Call

You May Also Like

PCN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure